{"id":6546,"date":"2013-01-17T00:01:13","date_gmt":"2013-01-17T05:01:13","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=6546"},"modified":"2013-01-17T00:01:13","modified_gmt":"2013-01-17T05:01:13","slug":"stocks-the-year-ahead","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/","title":{"rendered":"Stocks: The year ahead"},"content":{"rendered":"<p>A quick recap of the quarterly chart overview from December 2012:<\/p>\n<p>The S&amp;P 500 is headed for a test of its 2000\/2007 high at 1550. Declining 63-day Twiggs Momentum and a lackluster economy suggest that resistance is unlikely to be broken. Breach of the rising trendline would indicate a test of support at 1100.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" alt=\"S&amp;P 500 Index\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-01-16-spx.png?w=525&#038;ssl=1\" \/><\/p>\n<p>Canada&#8217;s TSX Composite Index is gaining momentum. Follow-through above 13000 would indicate another test of 15000.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" alt=\"Apple\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-01-16-tsx.png?w=525&#038;ssl=1\" \/><\/p>\n<p>Germany&#8217;s DAX threatens a breakout above 8000. Follow-through above 8200 would confirm a strong primary advance.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" alt=\"DAX Index\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-01-16-dax.png?w=525&#038;ssl=1\" \/><\/p>\n<p>The FTSE 100 broke resistance at 6000, suggesting an advance to 7000.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" alt=\"FTSE 100 Index\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-01-16-ftse.png?w=525&#038;ssl=1\" \/><\/p>\n<p>India&#8217;s Sensex is testing resistance at 21000. Rising momentum indicates breakout is likely, heralding a fresh primary advance.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" alt=\"BSE Sensex Index\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-01-16-bse.png?w=525&#038;ssl=1\" \/><\/p>\n<p>Singapore&#8217;s Straits Times Index lags behind, but breakout above 3300 is likely and would indicate an advance to 3900.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" alt=\"Apple\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-01-16-sti.png?w=525&#038;ssl=1\" \/><\/p>\n<p>The Shanghai Composite is headed for a re-test of long-term support at 1800\/1750. Rising momentum suggests that a bottom will form at this level. Recovery above 2500 and\/or the declining trendline would strengthen the signal.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" alt=\"Shanghai Composite Index\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-01-16-ssec.png?w=525&#038;ssl=1\" \/><\/p>\n<p>The ASX 200 is headed for a test of resistance at 5000, supported by rising 63-day Twiggs Momentum. Breakout would signal an advance to 6000, but weakness in China or the US may delay this for some time.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" alt=\"ASX 200 Index\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-01-16-xjo.png?w=525&#038;ssl=1\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A quick recap of the quarterly chart overview from December 2012: The S&amp;P 500 is headed for a test of its 2000\/2007 high at 1550. Declining 63-day Twiggs Momentum and a lackluster economy suggest that resistance is unlikely to be broken. Breach of the rising trendline would indicate a test of support at 1100. Canada&#8217;s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Stocks: The year ahead&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[40,41,12,57,33,34],"tags":[107,251,507,947,1481,3014,3100,3264],"class_list":["post-6546","post","type-post","status-publish","format-standard","hentry","category-australia-nz-countries-regions","category-china-hk","category-india-singapore-countries-regions","category-stock-markets","category-uk-europe-countries-regions","category-us-canada-countries-regions","tag-aapl","tag-asx-200","tag-bse-sensex","tag-dax","tag-ftse-100","tag-sp-500-index","tag-shanghai-composite-index","tag-straits-times-index"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Stocks: The year ahead - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stocks: The year ahead - the patient investor\" \/>\n<meta property=\"og:description\" content=\"A quick recap of the quarterly chart overview from December 2012: The S&amp;P 500 is headed for a test of its 2000\/2007 high at 1550. Declining 63-day Twiggs Momentum and a lackluster economy suggest that resistance is unlikely to be broken. Breach of the rising trendline would indicate a test of support at 1100. Canada&#8217;s &hellip; Continue reading &quot;Stocks: The year ahead&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:author\" content=\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-01-17T05:01:13+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2013\/2013-01-16-spx.png\" \/>\n<meta name=\"author\" content=\"Colin Twiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Colin Twiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/\"},\"author\":{\"name\":\"Colin Twiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\"},\"headline\":\"Stocks: The year ahead\",\"datePublished\":\"2013-01-17T05:01:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/\"},\"wordCount\":195,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-01-16-spx.png\",\"keywords\":[\"AAPL\",\"ASX 200\",\"BSE Sensex\",\"DAX\",\"FTSE 100\",\"S&amp;P 500 Index\",\"Shanghai Composite Index\",\"Straits Times Index\"],\"articleSection\":[\"Australia &amp; NZ\",\"China &amp; HK\",\"India &amp; Singapore\",\"Stock Markets\",\"UK &amp; Europe\",\"US &amp; Canada\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/\",\"name\":\"Stocks: The year ahead - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-01-16-spx.png\",\"datePublished\":\"2013-01-17T05:01:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#primaryimage\",\"url\":\"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-01-16-spx.png\",\"contentUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-01-16-spx.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stocks: The year ahead\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454\",\"name\":\"Colin Twiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"caption\":\"Colin Twiggs\"},\"description\":\"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.\",\"sameAs\":[\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\",\"https:\/\/au.linkedin.com\/in\/colintwiggs\"],\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stocks: The year ahead - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Stocks: The year ahead - the patient investor","og_description":"A quick recap of the quarterly chart overview from December 2012: The S&amp;P 500 is headed for a test of its 2000\/2007 high at 1550. Declining 63-day Twiggs Momentum and a lackluster economy suggest that resistance is unlikely to be broken. Breach of the rising trendline would indicate a test of support at 1100. Canada&#8217;s &hellip; Continue reading \"Stocks: The year ahead\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_author":"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","article_published_time":"2013-01-17T05:01:13+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2013\/2013-01-16-spx.png","type":"","width":"","height":""}],"author":"Colin Twiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Colin Twiggs","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/"},"author":{"name":"Colin Twiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454"},"headline":"Stocks: The year ahead","datePublished":"2013-01-17T05:01:13+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/"},"wordCount":195,"commentCount":0,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-01-16-spx.png","keywords":["AAPL","ASX 200","BSE Sensex","DAX","FTSE 100","S&amp;P 500 Index","Shanghai Composite Index","Straits Times Index"],"articleSection":["Australia &amp; NZ","China &amp; HK","India &amp; Singapore","Stock Markets","UK &amp; Europe","US &amp; Canada"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/","name":"Stocks: The year ahead - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-01-16-spx.png","datePublished":"2013-01-17T05:01:13+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-01-16-spx.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-01-16-spx.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/01\/17\/stocks-the-year-ahead\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Stocks: The year ahead"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454","name":"Colin Twiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","caption":"Colin Twiggs"},"description":"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.","sameAs":["https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","https:\/\/www.instagram.com\/colin_thepatientinvestor","https:\/\/au.linkedin.com\/in\/colintwiggs"],"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-1HA","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":13766,"url":"https:\/\/thepatientinvestor.com\/index.php\/2015\/03\/12\/dax-surges-ahead-while-others-retreat\/","url_meta":{"origin":6546,"position":0},"title":"DAX surges ahead while others retreat","author":"ColinTwiggs","date":"March 12, 2015","format":false,"excerpt":"The DAX is headed for its long-term target of 12000 while most markets (other than Japan) undergo a correction. The S&P 500 broke support at 2080, indicating a correction to test 2000. Breach of primary support is unlikely and another 13-week Twiggs Money Flow trough above zero would signal another\u2026","rel":"","context":"In &quot;Market Insights&quot;","block_context":{"text":"Market Insights","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/market-insights\/"},"img":{"alt_text":"S&P 500 Index","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-03-12-spx.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-03-12-spx.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-03-12-spx.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":6519,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/12\/24\/stocks-outlook-for-2013\/","url_meta":{"origin":6546,"position":1},"title":"Stocks: Outlook for 2013","author":"Colin Twiggs","date":"December 24, 2012","format":false,"excerpt":"Quarterly charts for the last two decades give a good idea of where stocks will be headed in 2013. The S&P 500 is headed for a test of its 2000\/2007 high at 1550. Declining 63-day Twiggs Momentum indicates that resistance is unlikely to be broken. While this does not mean\u2026","rel":"","context":"In &quot;Australia &amp; NZ&quot;","block_context":{"text":"Australia &amp; NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":13764,"url":"https:\/\/thepatientinvestor.com\/index.php\/2015\/02\/26\/the-rally-continues\/","url_meta":{"origin":6546,"position":2},"title":"The rally continues","author":"ColinTwiggs","date":"February 26, 2015","format":false,"excerpt":"Apart from China and India, last week's broad market rally is going strong, with the S&P 500 and the DAX making new highs. The S&P 500 broke resistance at 2100. Expect retracement to test the new support level, but respect is likely to confirm an advance to 2200*. Rising 13-week\u2026","rel":"","context":"In &quot;Market Insights&quot;","block_context":{"text":"Market Insights","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/market-insights\/"},"img":{"alt_text":"S&P 500 Index","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-02-26-spx.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-02-26-spx.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-02-26-spx.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":8378,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/09\/03\/global-markets-bearish-but-asx-india-find-support\/","url_meta":{"origin":6546,"position":3},"title":"Global markets bearish but ASX, India find support","author":"ColinTwiggs","date":"September 3, 2013","format":false,"excerpt":"US markets are closed for Labor Day. The S&P 500 ended last week testing its rising trendline and support at 1630. Breach would reinforce the bearish divergence on 21-day Twiggs Money Flow, indicating a test of primary support at 1560. Recovery above the descending trendline is unlikely at present, but\u2026","rel":"","context":"In &quot;Australia &amp; NZ&quot;","block_context":{"text":"Australia &amp; NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1019,"url":"https:\/\/thepatientinvestor.com\/index.php\/2015\/08\/06\/signs-of-improvement\/","url_meta":{"origin":6546,"position":4},"title":"Signs of improvement","author":"ColinTwiggs","date":"August 6, 2015","format":false,"excerpt":"Earnings results for the second quarter of 2015 remain on track. Of the 354 stocks in the S&P 500 that have reported, 252 (71%) beat, 26 met and 76 (21%) missed their estimates. The S&P 500 has lost momentum since March 2015, consolidating below resistance at 2130. Gradual decline of\u2026","rel":"","context":"In &quot;Market Insights&quot;","block_context":{"text":"Market Insights","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/market-insights\/"},"img":{"alt_text":"S&P 500 Index","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-08-06-spx.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-08-06-spx.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2015\/2015-08-06-spx.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":8048,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/07\/09\/european-rally-follows-us-lead\/","url_meta":{"origin":6546,"position":5},"title":"European rally follows US lead","author":"ColinTwiggs","date":"July 9, 2013","format":false,"excerpt":"The S&P 500 Index penetrated its descending trendline, indicating the correction has ended. Follow-through above 1650 would signal a primary advance to 1800*. * Target calculation: 1680 + ( 1680 - 1560 ) = 1800 The FTSE 100 broke through medium-term resistance at 6400, confirming the correction has ended, after\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/6546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=6546"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/6546\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=6546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=6546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=6546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}